Germany Niubian Recalled for Lack of FDA Approval
R Thomas Marketing, LLC is recalling Germany Niubian capsules because they were marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which per the rubric mandates a score of 5 (Critical) regardless of other factors.
Plain-English summary
R Thomas Marketing, LLC is recalling Germany Niubian, a product packaged in BIG BOX (10 small boxes / 24 capsules per box / 240 capsules). The product was distributed nationwide via Internet sales.
The recall is being conducted because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). This means the product has not been evaluated by the FDA for safety, efficacy, or quality.
Consumers who have purchased this product should stop using it and contact the distributor for further instructions.
The recalled product
- Product
- Germany Niubian, packaged in BIG BOX (10 small boxes / 24 capsules per box / 240 capsules), Distributed by: R Thomas Marketing, LLC, Bronx, NY 10467
- Manufacturer
- R Thomas Marketing, LLC
- Category
- Drug — Unapproved Drug
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 24 recalled by R Thomas Marketing, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 24 products in this recall →Related recalls
Same manufacturer · R Thomas Marketing, LLC
See all →- SevereMan King capsules recalled for lack of FDA approval
FDA (Drugs) · 2016-06-01
- SevereFDA Recalls Black Storm Capsules Marketed Without Approval
FDA (Drugs) · 2016-06-01
- SevereFDA Recalls Zhen Gong Fu for Lack of Approved New Drug Application
FDA (Drugs) · 2016-06-01
- SevereBull's Genital Recalled for Marketing Without FDA Approval
FDA (Drugs) · 2016-06-01
- SeverePlant Vigra Recalled for Lack of FDA Approval
FDA (Drugs) · 2016-06-01
Same hazard · unapproved drug
See all →- CriticalBuy-Herbal Recalls Kian Pee Wan Capsules for Undeclared Drug Ingredients
FDA (Drugs) · 2026-08-19
- SevereMR. 7 Super capsules recalled as Class I over undeclared sildenafil
FDA (Drugs) · 2026-03-11
- SevereMojo Max Fusion capsules recalled as Class I over undeclared drug ingredients
FDA (Drugs) · 2026-03-11
- SevereSilintan herbal pills recalled as Class I for undeclared meloxicam
FDA (Drugs) · 2026-03-11
- SevereAgebox iKids-Growth Day Formula Capsules Recalled Over Undeclared Drug Ingredient
FDA (Drugs) · 2026-03-04
Similar recalls
- SevereGermany Niubian tablets recalled for containing unapproved sildenafil
FDA (Drugs) · 2018-02-07
- SevereFUCONPO Capsule Recalled for Marketing Without Approved NDA or ANDA
FDA (Drugs) · 2016-07-20
- CriticalFDA Recalls Unapproved Zhonghua Niubian Tablets Containing Sildenafil
FDA (Drugs) · 2018-02-07
- CriticalLiDa DAIDAIHUA capsules recalled for undeclared sibutramine and phenolphthalein
FDA (Drugs) · 2015-11-25
- ModeratePeking Niu-Huang Chieh-Tu-Pien Tablets Recalled for Unapproved Drug Claims
FDA (Drugs) · 2016-07-20
- ModerateBasic Reset Recalls Nuovi Firming Masque for Lack of FDA Approval
FDA (Drugs) · 2019-11-13